PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Clinical trials for PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY trials appear
Sign up with your email to follow new studies for PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug targets deadly brain virus in small trial
Disease control Recruiting nowThis phase 2 trial tests the safety of brincidofovir, an antiviral drug, in 24 adults with progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. Participants receive the drug intravenously twice a week for up to 12 weeks, with follow-up …
Matched conditions: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Phase: PHASE2 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Could immune checkpoint drugs tame a deadly brain virus?
Disease control Recruiting nowThis study is testing whether immune checkpoint inhibitors, drugs that help the immune system fight infections, can improve outcomes for people with progressive multifocal leukoencephalopathy (PML), a rare brain virus. Researchers will follow 66 patients over a year, measuring di…
Matched conditions: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Sponsor: Peking Union Medical College Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Scientists launch major study to unravel mysteries of rare brain infection PML
Knowledge-focused Recruiting nowThis study follows 700 people with progressive multifocal leukoencephalopathy (PML), a rare brain infection caused by the JC virus. Researchers will collect blood, spinal fluid, and brain scans over time to understand how the disease progresses. No treatment is given; the goal is…
Matched conditions: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New tracer could reveal hidden immune activity in brain diseases
Knowledge-focused Recruiting nowThis pilot study tests whether a radioactive tracer called 89Zr-Df-crefmirlimab can help PET scans detect certain immune cells (CD8+ T cells) in the brain and spinal cord of people with multiple sclerosis (MS) or progressive multifocal leukoencephalopathy (PML). About 15 adults w…
Matched conditions: PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY
Phase: PHASE1 • Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC